{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T19:52:06Z","timestamp":1772913126337,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004881","name":"Instituto Mexicano del Seguro Social","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.arcmed.2019.12.006","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T19:59:58Z","timestamp":1582055998000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cord Blood Banking and Transplantation in a National Program: Thirteen Years of Experience"],"prefix":"10.1016","volume":"51","author":[{"given":"\u00c1ngel","family":"Guerra-M\u00e1rquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Pe\u00f1aflor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector","family":"Mayani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2019.12.006_bib1","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1073\/pnas.86.10.3828","article-title":"Human umbilical cord blood as a potential source of transplantable hematopoietic stem\/progenitor cells","volume":"86","author":"Broxmeyer","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2019.12.006_bib2","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM198910263211707","article-title":"Hematopoietic reconstitution of a patient with Fanconi anemia by means of umbilical cord blood from an HLA-identical sibling","volume":"321","author":"Gluckman","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2019.12.006_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.arcmed.2011.11.010","article-title":"Umbilical cord blood: lessons learned and lingering challenges after more than 20 years of basic and clinical research","volume":"42","author":"Mayani","year":"2011","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2019.12.006_bib4","first-page":"621","article-title":"History of cord blood transplantation","volume":"44","author":"Gluckman","year":"2009","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.arcmed.2019.12.006_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/j.seminhematol.2016.08.002","article-title":"Umbilical cord blood cells from unrelated donor as an alternative source of hematopoietic stem cells for transplantation in children and adults","volume":"53","author":"Rocha","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.arcmed.2019.12.006_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bjh.13926","article-title":"Cord blood transplant for acute myeloid leukemia","volume":"173","author":"Ballen","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcmed.2019.12.006_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood-2013-02-453175","article-title":"Umbilical cord blood transplantation: the first 25 years","volume":"122","author":"Ballen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2019.12.006_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2141.2009.07827.x","article-title":"Cord blood banking: A historical perspective","volume":"147","author":"Navarrete","year":"2009","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.arcmed.2019.12.006_bib9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/bmt.2015.124","article-title":"Umbilical cord blood donation: public or private?","volume":"50","author":"Ballen","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.arcmed.2019.12.006_bib10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1080\/14653240600920790","article-title":"Banking and transplantation of umbilical cord blood in Guangzhou, China","volume":"8","author":"Wu","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.arcmed.2019.12.006_bib11","first-page":"1055","article-title":"Collection and processing of umbilical cord blood for cryopreservation","volume":"86","author":"U-pratya","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.arcmed.2019.12.006_bib12","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/bmt.2009.350","article-title":"Unrelated cord blood transplantation in pediatric patients: a report from Saudi Arabia","volume":"45","author":"Ayas","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.arcmed.2019.12.006_bib13","first-page":"105","article-title":"Quality control measures in cord blood banking in India-critical appraisal and recommendations","volume":"8","author":"Vaidya","year":"2013","journal-title":"J Stem Cells"},{"key":"10.1016\/j.arcmed.2019.12.006_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.transci.2013.09.012","article-title":"Cord blood banking activity in Iran National Cord Blood Bank: a two year experience","volume":"50","author":"Jamali","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.arcmed.2019.12.006_bib15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1590\/S0100-879X2006001000005","article-title":"Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution","volume":"39","author":"De Medeiros","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.arcmed.2019.12.006_bib16","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1016\/j.transproceed.2013.08.093","article-title":"Umbilical cord blood transplantation in hematologic diseases in patients over 15 years old: long-term experience at the Pontificia Universidad Catolica de Chile","volume":"45","author":"Ramirez","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2019.12.006_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/10245330600921980","article-title":"Umbilical cord blood transplantation using non-myeloablative conditioning: the Mexican experience","volume":"11","author":"Mancias\u2013Guerra","year":"2006","journal-title":"Hematology"},{"key":"10.1016\/j.arcmed.2019.12.006_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00277-005-0037-5","article-title":"Clinical relevance of NK, NKT and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation","volume":"85","author":"Vela-Ojeda","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1016\/j.arcmed.2019.12.006_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/scd.2009.0216","article-title":"Role of CD4+ CD25+ highFoxP3+ CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Vela-Ojeda","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.arcmed.2019.12.006_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1537-2995.2007.01529.x","article-title":"Establishing a cord blood banking and transplantation program in Mexico: A single institution experience","volume":"48","author":"Novelo-Garza","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.arcmed.2019.12.006_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1537-2995.2010.02875.x","article-title":"Cord blood banking and transplantation at the Mexican Institute of Social Security: The first five years","volume":"51","author":"Guerra-Marquez","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.arcmed.2019.12.006_bib22","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1046\/j.1537-2995.2002.00227.x","article-title":"A phased consent policy for cord blood donation","volume":"42","author":"Vawter","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.arcmed.2019.12.006_bib23","series-title":"Cord blood: biology, immunology, banking and clinical transplantation","first-page":"219","article-title":"Umbilical cord blood banking","author":"Chrysler","year":"2004"},{"key":"10.1016\/j.arcmed.2019.12.006_bib24","doi-asserted-by":"crossref","first-page":"463031","DOI":"10.1155\/2013\/463031","article-title":"A review of the factors influencing the banking of collected Umbilical Cord Blood units","volume":"2013","author":"Allan","year":"2013","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.arcmed.2019.12.006_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/scd.2009.0327","article-title":"Biological differences between neonatal and adult human hematopoietic stem\/progenitor cells","volume":"19","author":"Mayani","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.arcmed.2019.12.006_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fmed.2015.00095","article-title":"Is there any reason to prefer cord blood instead of adult donors for hematopoietic stem cell transplants?","volume":"2","author":"Beksac","year":"2016","journal-title":"Front Med"},{"key":"10.1016\/j.arcmed.2019.12.006_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fmed.2015.00094","article-title":"Cord blood banking standards: autologous vs altruistic","volume":"2","author":"Armitage","year":"2016","journal-title":"Front Med"},{"key":"10.1016\/j.arcmed.2019.12.006_bib28","series-title":"Cord blood: biology, immunology, banking and clinical transplantation","first-page":"429","article-title":"The international NETCORD foundation","author":"Wernet","year":"2004"},{"key":"10.1016\/j.arcmed.2019.12.006_bib29","series-title":"International standards for cord blood collection, processing, testing, banking, selection, and release","year":"2001"},{"key":"10.1016\/j.arcmed.2019.12.006_bib30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2019.12.006_bib31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/bmt.2014.312","article-title":"Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants","volume":"50","author":"Passweg","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.arcmed.2019.12.006_bib32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4252\/wjsc.v6.i4.371","article-title":"Haploidentical vs cord blood transplantation for adults with acute myelogenous leukemia","volume":"6","author":"Solh","year":"2014","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.arcmed.2019.12.006_bib33","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/bmt.2009.291","article-title":"Pediatric related and unrelated cord blood transplantation for malignant diseases","volume":"44","author":"Rocha","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.arcmed.2019.12.006_bib34","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)60915-5","article-title":"Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study","volume":"369","author":"Eapen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2019.12.006_bib35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2141.2009.07828.x","article-title":"Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood","volume":"147","author":"Smith","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcmed.2019.12.006_bib36","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3324\/haematol.2010.038836","article-title":"An overview of the progress on double umbilical cord blood transplantation","volume":"96","author":"Sideri","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.arcmed.2019.12.006_bib37","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1405584","article-title":"One-unit versus two-unit cord blood transplantation for hematologic cancers","volume":"371","author":"Wagner","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2019.12.006_bib38","first-page":"3662","article-title":"Factors associated with outcome after cord blood transplantation in children with acute leukemia","volume":"93","author":"Locatelli","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2019.12.006_bib39","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/MOH.0b013e3283136718","article-title":"Unrelated donor umbilical cord blood transplantation for the treatment of hematologic malignancies","volume":"15","author":"Sauter","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.arcmed.2019.12.006_bib40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(95)91268-1","article-title":"Allogeneic sibling umbilical cord blood transplantation in children with malignant and non-malignant disease","volume":"346","author":"Wagner","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2019.12.006_bib41","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2002-01-0294","article-title":"Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non-malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival","volume":"100","author":"Wagner","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2019.12.006_bib42","first-page":"89","article-title":"Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Capellano","year":"2007","journal-title":"New Microbiol"},{"key":"10.1016\/j.arcmed.2019.12.006_bib43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajh.21886","article-title":"Current status of pediatric umbilical cord blood transplantation in Korea: A multicenter retrospective analysis of 236 cases","volume":"86","author":"Yoo","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.arcmed.2019.12.006_bib44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.bbmt.2014.12.038","article-title":"Bloodstream infections in adult patients undergoing cord blood transplantation from unrelated donors after myeloablative conditioning regimen","volume":"21","author":"Sanz","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.arcmed.2019.12.006_bib45","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1186\/s12879-018-3575-x","article-title":"The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study","volume":"18","author":"Ge","year":"2018","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.arcmed.2019.12.006_bib46","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.bbmt.2016.06.012","article-title":"Infection rates among acute leukemia patients receiving alternative donor hematopoietic cell transplantation","volume":"22","author":"Ballen","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.arcmed.2019.12.006_bib47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.21037\/sci.2017.05.06","article-title":"From patient centered risk factors to comprehensive prognostic models: a suggested framework for outcome prediction in umbilical cord blood transplantation","volume":"4","author":"Shouval","year":"2017","journal-title":"Stem Cell Investig"},{"key":"10.1016\/j.arcmed.2019.12.006_bib48","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1537-2995.2012.03799.x","article-title":"Comparative in vitro analysis of different hematopoietic cell populations from human cord blood: In search of the best option for clinically-oriented ex vivo cell expansion","volume":"53","author":"Flores-Guzman","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.arcmed.2019.12.006_bib49","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1089\/scd.2016.0071","article-title":"Bone marrow mesenquimal stromal cells from clinical scale culture: in vitro evaluation of their differentiation, hematopoietic support, and immunosuppressive capacities","volume":"25","author":"Fajardo-Ordu\u00f1a","year":"2016","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.arcmed.2019.12.006_bib50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/bmt.2009.290","article-title":"Umbilical cord blood transplantation for nonmalignant diseases","volume":"44","author":"Prasad","year":"2009","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.arcmed.2019.12.006_bib51","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/pr.2017.254","article-title":"Cell therapy for diverse central nervous system disorders: inherited metabolic diseases and autism","volume":"83","author":"Sun","year":"2018","journal-title":"Pediatr Res"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440919306708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440919306708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:48:24Z","timestamp":1759261704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440919306708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0188440919306708"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2019.12.006","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cord Blood Banking and Transplantation in a National Program: Thirteen Years of Experience","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2019.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 IMSS. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}